to High-Density Lipoprotein, Dyslipidemia, and Coronary Heart Disease -- Regulation of ApoA-I Gene Expression and Prospects to Increase Plasma ApoA-I and HDL Levels -- High Density Lipoprotein Particles -- The Kinetics and Remodeling of HDL Particles: Lessons from Inborn Errors of Lipid Metabolism -- HDL Structure, Function, and Antiinflammatory Properties -- Human Apolipoprotein A-I Deficiency -- Human Apolipoprotein A-I Mutants -- ATP Binding Cassette A1 Transporter Function and Tangier Disease -- The Role ABCG1 in Cellular Cholesterol Efflux: Relevance to Atherosclerosis and Endothelial Function -- In Vitro Studies and Mass Flux of Cholesterol Between Serum and Macrophages -- Genetic LCAT Deficiency: Molecular Diagnosis, Plasma Lipids, and Atherosclerosis -- Human Cholesteryl Ester Transfer Protein in Human HDL Metabolism -- The HDL Receptor SR-BI -- Genetic Loci Influencing Plasma High Density Lipoprotein Cholesterol Concentrations in Humans -- Nutritional and Lifestyle Factors and High-Density Lipoprotein Metabolism -- Effects of Ethanol Intake on High Density Lipoprotein Metabolism in Humans -- Effects of Estrogen on HDL Metabolism -- Effects of Niacin on HDL Metabolism -- Effects of Statins on HDL Metabolism -- Therapeutic Regulation of High-Density Lipoprotein Transport in the Metabolic Syndrome -- Effects of Cholesterol Ester Transfer Protein Inhibition on HDL Metabolism -- HDL Infusion Therapy -- High Density Lipoproteins, Dyslipidemia, and Heart Disease: Past, Present, and Future.

This innovative book focuses on HDL and its relationships to triglyceride-rich particles. As new therapies for HDL raising become available, a comprehensive understanding the role of HDL in Coronary Heart Disease is of great importance. This book is an excellent resource for educating physicians and scientists about dyslipidemia and HDL metabolism, including many exogenous substances which interact with and influence HDL. Readers will benefit from the unique visual exposition and the insights of international experts.